Astia Angels and Wheatsheaf Group have backed the genomic analytics firm in its latest funding round.
"We have developed innovative analytics and AI capabilities that enable a new generation of precision medicine and precision agriculture solutions. The ability to deliver combinatorial, multi-omic analysis at scale is a critical missing piece in realising the benefits of the genomics, IOT and AI revolutions. This investment will enable us to scale our business to address the significant global opportunities in these high-growth markets."
The doctor-on-demand application closed the crowd and angel raise at a post-money valuation of £5.2m.
"We’re delighted to welcome Dr Sandeep, Hiten and Yann to our growing team at Qured at such an exciting time in the company’s journey. From initially just covering Clapham to now providing our service to South West London and Zones 1 and 2 in just over six months is both fulfilling and exciting. It reinforces our belief that there is a heightened demand for an affordable and convenient healthcare service which works around people’s lives, offering easier, quicker and hassle-free access to primary healthcare."
The funding round was led by the Angel CoFund, Beltrae Partners, and TechStart NI.
"The first generation of wearable tech devices had a huge impact on the world, helping millions better understand their physical output. Modius is part of an exciting second generation of wearable tech and is a product that actually and actively improves health rather than simply measuring. We believe there are tens of millions of people who will find they can become leaner through use of the Modius device. We also know that neuroscience and technology can be combined to affect all sorts of other health issues which in effect gives our company a very robust product pipeline."
